Voraxaze 1000 [USP'U]/1
glucarpidase · INJECTION, POWDER, FOR SOLUTION · BTG International Inc.
Voraxaze is a injection, powder, for solution containing glucarpidase at 1000 [USP'U]/1, taken intravenous. Manufactured by BTG International Inc..
Key Facts
- Brand Name
- Voraxaze
- Generic Name
- glucarpidase
- NDC Code (Product)
50633-210- Manufacturer
- BTG International Inc.
- Strength
- 1000 [USP'U]/1
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125327
- Drug Class
- Carboxypeptidase [EPC]
- Marketing Start
- 04/01/2012
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Voraxaze used for?
Voraxaze contains glucarpidase. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is Voraxaze a controlled substance?
Voraxaze is not classified as a controlled substance by the DEA.
What is the generic name for Voraxaze?
The generic name for Voraxaze is glucarpidase. There are no other listed brand versions of glucarpidase.
What is the NDC code for Voraxaze 1000 [USP'U]/1?
The NDC (National Drug Code) for Voraxaze 1000 [USP'U]/1 is 50633-210, listed by BTG International Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)